Deepankar Chakroborty
Genentech · 57 works · 242 citations · h-index 8
Top works
- Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells
- The L1TD1 Protein Interactome Reveals the Importance of Post-transcriptional Regulation in Human Pluripotency
- An unbiased in vitro screen for activating epidermal growth factor receptor mutations
- DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer
- L1TD1 - a prognostic marker for colon cancer
- Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
- Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
- Trans-activating mutations of the pseudokinase ERBB3
- An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations
- Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response
- Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases
- Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers
- Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies
- Table S4 from Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases
- Abstract 153: An unbiased in vitro screen for activating ERBB4 mutations
- Abstract 2420: Characterizing the oncogenic activity of ERBB4 mutations and their sensitivity to neratinib
- Abstract 3500: A pipeline to identify driver mutations
- Table S5 from Identification of Predictive ERBB Mutations by Leveraging Publicly Available Cell Line Databases
- Abstract 828: Screen for actionable ERBB3 mutations
- Transcriptional landscape of DTP-DTEP transition reveals DUSP6 as a driver of HER2 inhibitor tolerance via Neuregulin/HER3 axis